Compounds > 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Page last updated: 2024-10-21

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Aqueductal Stenosis

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Aqueductal Stenosis in 1 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Research Excerpts

ExcerptRelevanceReference
"All high dose animals showed hydrocephalus which was also observed in four other animals receiving bFGF."1.29Intraventricular infusion of basic fibroblast growth factor (bFGF) in the MPTP-treated common marmoset. ( Collins, P; Emmett, C; Jenner, P; Marsden, CD; Pearce, RK, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pearce, RK1
Collins, P1
Jenner, P1
Emmett, C1
Marsden, CD1

Other Studies

1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Aqueductal Stenosis

ArticleYear
Intraventricular infusion of basic fibroblast growth factor (bFGF) in the MPTP-treated common marmoset.
    Synapse (New York, N.Y.), 1996, Volume: 23, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain; Brain Chemistry; Call

1996